SQZ Biotechnologies Co

NYSE:SQZ   2:46:28 PM EDT
-0.10 (-3.96%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)74.95M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$4.7 Million
Adjusted EPS-$0.78
See more estimates
10-Day MA$2.63
50-Day MA$2.70
200-Day MA$3.47
See more pivots

SQZ Biotechnologies Co Stock, NYSE:SQZ

200 Arsenal Yards Boulevard, Suite 210, Watertown, Massachusetts 02472
United States of America
Phone: +1.617.758.8672
Number of Employees: 116


SQZ Biotechnologies Co. is a clinical-stage biotechnology company, which engages in developing cell therapies for patients with cancer, infectious diseases, and other serious conditions. It operates through SQZ cell therapy platform, which uses membrane disruption to deliver material into cells. The company was founded by Robert S. Langer Jr., Klavis F. Jensen, Agustin Lopez Marquez, and Armon Sharei in March 2013 and is headquartered in Watertown, MA.